64 related articles for article (PubMed ID: 21108647)
1. Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus.
Aspriello SD; Zizzi A; Tirabassi G; Buldreghini E; Biscotti T; Faloia E; Stramazzotti D; Boscaro M; Piemontese M
J Periodontal Res; 2011 Apr; 46(2):164-9. PubMed ID: 21108647
[TBL] [Abstract][Full Text] [Related]
2. Effects of Systemic Simvastatin on the Concentrations of Visfatin, Tumor Necrosis Factor-
Bahammam MA; Attia MS
J Immunol Res; 2018; 2018():8481735. PubMed ID: 30186882
[TBL] [Abstract][Full Text] [Related]
3. Complement 3 mediates periodontal destruction in patients with type 2 diabetes by regulating macrophage polarization in periodontal tissues.
Li Y; Wang X; Wang S; Zhu C; Guo J; Li K; Li A
Cell Prolif; 2020 Oct; 53(10):e12886. PubMed ID: 32794619
[TBL] [Abstract][Full Text] [Related]
4. Salivary Interleukin-6 as a Non-Invasive Biomarker for Chronic Periodontitis and Tooth Loss in Type 2 Diabetes.
Sangappa SB; Babu HM; Savadi RC; Krishnamurthy PT; Ravi Kiran AVVV
Indian J Dent Res; 2024 Jan; 35(1):28-33. PubMed ID: 38934745
[TBL] [Abstract][Full Text] [Related]
5. Periodontitis and type 2 diabetes among women with previous gestational diabetes: epidemiological and immunological aspects in a follow-up of three years.
Esteves Lima RP; Cota LO; Silva TA; Cortelli SC; Cortelli JR; Costa FO
J Appl Oral Sci; 2017; 25(2):130-139. PubMed ID: 28403353
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and microbial biomarkers for periodontitis and type 2 diabetes mellitus.
Li S; Li H; Kong H; Wu SY; Cheng CK; Xu J
Front Endocrinol (Lausanne); 2023; 14():1292596. PubMed ID: 38149100
[TBL] [Abstract][Full Text] [Related]
7. Clinical Study on the Implications of Immunological Markers in the Diagnosis of Periodontitis in People with Diabetes Mellitus.
Dinu A; Antonescu OR
Dent J (Basel); 2024 May; 12(6):. PubMed ID: 38920850
[TBL] [Abstract][Full Text] [Related]
8. Exploring Interleukin Levels in Type 1 Diabetes and Periodontitis: A Review with a Focus on Childhood.
D'Agostino S; Valentini G; Dolci M
Children (Basel); 2024 Feb; 11(2):. PubMed ID: 38397350
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk" [Immunology Letters 254 (2023) 1-5].
Nussrat SW; Ad'hiah AH
Immunol Lett; 2023 Nov; 263():135-137. PubMed ID: 37468424
[No Abstract] [Full Text] [Related]
10. Diabetes and periodontal disease. Review of the literature.
Bascones-Martínez A; González-Febles J; Sanz-Esporrín J
Am J Dent; 2014 Apr; 27(2):63-7. PubMed ID: 25000662
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin A1c levels among patients with diabetes receiving nonsurgical periodontal treatment--reply.
Engebretson SP; Hyman LG; Michalowicz BS
JAMA; 2014 May; 311(18):1921-2. PubMed ID: 24825652
[No Abstract] [Full Text] [Related]
12. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial.
Engebretson SP; Hyman LG; Michalowicz BS; Schoenfeld ER; Gelato MC; Hou W; Seaquist ER; Reddy MS; Lewis CE; Oates TW; Tripathy D; Katancik JA; Orlander PR; Paquette DW; Hanson NQ; Tsai MY
JAMA; 2013 Dec; 310(23):2523-32. PubMed ID: 24346989
[TBL] [Abstract][Full Text] [Related]
13. Quantification of key periodontal pathogens in insulin-dependent type 2 diabetic and non-diabetic patients with generalized chronic periodontitis.
Aemaimanan P; Amimanan P; Taweechaisupapong S
Anaerobe; 2013 Aug; 22():64-8. PubMed ID: 23827459
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of periodontal treatment to improve metabolic control in patients with chronic periodontitis and type 2 diabetes: a meta-analysis of randomized clinical trials.
Sgolastra F; Severino M; Pietropaoli D; Gatto R; Monaco A
J Periodontol; 2013 Jul; 84(7):958-73. PubMed ID: 23106512
[TBL] [Abstract][Full Text] [Related]
15. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes.
Field CA; Gidley MD; Preshaw PM; Jakubovics N
J Periodontal Res; 2012 Aug; 47(4):470-8. PubMed ID: 22220967
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases.
Lalla E; Papapanou PN
Nat Rev Endocrinol; 2011 Jun; 7(12):738-48. PubMed ID: 21709707
[TBL] [Abstract][Full Text] [Related]
17. Nomogram-Based Chronic Kidney Disease Prediction Model for Type 1 Diabetes Mellitus Patients Using Routine Pathological Data.
Chowdhury NH; Reaz MBI; Ali SHM; Ahmad S; Crespo ML; Cicuttin A; Haque F; Bakar AAA; Bhuiyan MAS
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143293
[TBL] [Abstract][Full Text] [Related]
18. Expression of TNF-
Qian J; Huang Y
Comput Math Methods Med; 2022; 2022():9073372. PubMed ID: 35979044
[TBL] [Abstract][Full Text] [Related]
19. Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients.
Chowdhury NH; Reaz MBI; Haque F; Ahmad S; Ali SHM; A Bakar AA; Bhuiyan MAS
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943504
[TBL] [Abstract][Full Text] [Related]
20. Anti-Inflammatory and Antioxidant Properties of Carvacrol and Magnolol, in Periodontal Disease and Diabetes Mellitus.
Cicalău GIP; Babes PA; Calniceanu H; Popa A; Ciavoi G; Iova GM; Ganea M; Scrobotă I
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
